SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019945
Filing Date
2018-08-07
Accepted
2018-08-07 16:17:58
Documents
60
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-10q_20180630.htm 10-Q 1355459
2 EX-31.1 crsp-ex311_7.htm EX-31.1 19671
3 EX-31.2 crsp-ex312_8.htm EX-31.2 19738
4 EX-32.1 crsp-ex321_6.htm EX-32.1 7754
  Complete submission text file 0001564590-18-019945.txt   6979165

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT crsp-20180630.xml EX-101.INS 1782195
6 XBRL TAXONOMY EXTENSION SCHEMA crsp-20180630.xsd EX-101.SCH 48703
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crsp-20180630_cal.xml EX-101.CAL 35090
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crsp-20180630_def.xml EX-101.DEF 201296
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20180630_lab.xml EX-101.LAB 370756
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20180630_pre.xml EX-101.PRE 310643
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 18998332
SIC: 2836 Biological Products, (No Diagnostic Substances)